Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

MeiraGTx Holdings plc (MGTX)

13.53   0.44 (3.36%) 09-20 00:09
Open: 13.29 Pre. Close: 13.09
High: 13.64 Low: 12.62
Volume: 187,309 Market Cap: 506M
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. The company is headquartered in New York, New York and currently employs 130 full-time employees. The firm develops gene therapy treatments for a range of inherited and acquired disorders. The company is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). The company is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. The company is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, A006, AAV-AQP1 and AAV-UPF1.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.653 - 13.719 13.719 - 13.776
Low: 12.47 - 12.542 12.542 - 12.605
Close: 13.415 - 13.534 13.534 - 13.636

Technical analysis

as of: 2020-09-18 4:33:19 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 17.25     One year: 20.15
Support: Support1: 13.06    Support2: 12.01
Resistance: Resistance1: 14.77    Resistance2: 17.25
Pivot: 13.01
Moving Average: MA(5): 13.34     MA(20): 13.14
MA(100): 13.65     MA(250): 15.37
MACD: MACD(12,26): -0.04     Signal(9): -0.10
Stochastic oscillator: %K(14,3): 50.85     %D(3): 54.02
RSI: RSI(14): 53.23
52-week: High: 22.32  Low: 8.82  Change(%): -26.1
Average Vol(K): 3-Month: 12644  10-Days: 20523

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MGTX has closed below upper band by 10.9%. Bollinger Bands are 48.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to MGTX's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 17 Sep 2020
MeiraGTx Holdings plc [MGTX] Revenue clocked in at $17.20 million, down -31.97% YTD: What’s Next? - The DBT News

Thu, 17 Sep 2020
After A -31.97% Fall This Year Is MeiraGTx Holdings plc (NASDAQ:MGTX) A Better Buy Than Others? - Marketing Sentinel

Wed, 16 Sep 2020
MeiraGTx Holdings plc [MGTX] Is Still Undervalued at $13.91 - mzpnews.com

Wed, 16 Sep 2020
MeiraGTx Holdings plc (NASDAQ:MGTX) Is a Buzzing Hot Stock - Stocks Register

Wed, 16 Sep 2020
Do Analysts Expect MeiraGTx Holdings PLC (MGTX) Stock to Rise? - InvestorsObserver

Wed, 16 Sep 2020
MeiraGTx (NASDAQ:MGTX) Research Coverage Started at BofA Securities - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37
Shares Float (M) 15
% Held by Insiders 33.79
% Held by Institutions 47.17
Shares Short (K) 427
Shares Short P. Month (K) 453

Stock Financials

EPS -1.580
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.620
Profit Margin
Operating Margin -332.71
Return on Assets (ttm) -13.2
Return on Equity (ttm) -37.7
Qtrly Rev. Growth 24.8
Gross Profit (p.s.) 0.356
Sales Per Share 0.461
EBITDA (p.s.) -1.453
Qtrly Earnings Growth
Operating Cash Flow (M) -66
Levered Free Cash Flow (M) -54

Stock Valuations

PE Ratio -8.56
PEG Ratio
Price to Book value 2.93
Price to Sales 29.37
Price to Cash Flow -7.70

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.